Literature DB >> 8302878

High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains.

H G Cheon1, W J LaRochelle, D P Bottaro, W H Burgess, S A Aaronson.   

Abstract

Growth factors of the fibroblast growth factor (FGF) family bind receptors whose external domains are organized in a series of immunoglobulin-like loops. We engineered expression constructs in which cDNAs encoding individual immunoglobulin-like domains of the keratinocyte growth factor (KGF/FGF-7) receptor were fused to the mouse immunoglobulin heavy chain Fc domain (HFc). Each chimera was efficiently secreted from NIH 3T3 transfectants and migrated at the predicted molecular mass after SDS/PAGE. Scatchard analysis revealed that the chimera containing immunoglobulin-like domains 2 (D2) and 3 (D3) bound KGF and acidic FGF at high affinities comparable to the native receptor. However, individual immunoglobulin-like domain chimeras demonstrated marked specificity in their ligand interactions. D2-HFc bound acidic FGF at high affinity, whereas it did not detectably interact with KGF. Conversely, D3-HFc bound KGF at high affinity but exhibited no detectable interaction with acidic FGF. Their selective ligand binding properties were confirmed by the specific neutralization of acidic FGF or KGF mitogenic activity using D2 or D3 HFc, respectively. All of these findings establish that the major binding sites for related FGF ligands are localized to distinct receptor immunoglobulin-like domains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302878      PMCID: PMC521439          DOI: 10.1073/pnas.91.3.989

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

Review 2.  Antibody-antigen complexes.

Authors:  D R Davies; S Sheriff; E A Padlan
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

3.  The binding site for C1q on IgG.

Authors:  A R Duncan; G Winter
Journal:  Nature       Date:  1988-04-21       Impact factor: 49.962

4.  The characterization of the receptor for endothelial cell growth factor by covalent ligand attachment.

Authors:  R Friesel; W H Burgess; T Mehlman; T Maciag
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

Review 5.  The immunoglobulin superfamily--domains for cell surface recognition.

Authors:  A F Williams; A N Barclay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

6.  Localization of the binding site for the human high-affinity Fc receptor on IgG.

Authors:  A R Duncan; J M Woof; L J Partridge; D R Burton; G Winter
Journal:  Nature       Date:  1988-04-07       Impact factor: 49.962

Review 7.  Immunoglobulin G: functional sites.

Authors:  D R Burton
Journal:  Mol Immunol       Date:  1985-03       Impact factor: 4.407

8.  BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines.

Authors:  B E Weissman; S A Aaronson
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

9.  Identification of a major binding site for complement C3 on the IgG1 heavy chain.

Authors:  J M Shohet; P Pemberton; M C Carroll
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

10.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

View more
  8 in total

1.  Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.

Authors:  G Venkataraman; R Raman; V Sasisekharan; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands.

Authors:  Changyu Zheng; Ana P Cotrim; Anne Rowzee; William Swaim; Anastasia Sowers; James B Mitchell; Bruce J Baum
Journal:  Clin Cancer Res       Date:  2011-03-02       Impact factor: 12.531

3.  Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue.

Authors:  Lejla Pasic; T S Karin Eisinger-Mathason; Bisi T Velayudhan; Christopher A Moskaluk; David R Brenin; Ian G Macara; Deborah A Lannigan
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

4.  Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning.

Authors:  G Celli; W J LaRochelle; S Mackem; R Sharp; G Merlino
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

5.  The fibroblast growth factor receptor, FGFR3, forms gradients of intact and degraded protein across the growth plate of developing bovine ribs.

Authors:  Sujata G Pandit; Prasanthi Govindraj; Joachim Sasse; Peter J Neame; John R Hassell
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

6.  Heparin can activate a receptor tyrosine kinase.

Authors:  G Gao; M Goldfarb
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

7.  Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera.

Authors:  W J LaRochelle; O R Dirsch; P W Finch; H G Cheon; M May; C Marchese; J H Pierce; S A Aaronson
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

Review 8.  Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?

Authors:  Young Kwang Chae; Ayush Arya; Lauren Chiec; Hiral Shah; Ari Rosenberg; Sandip Patel; Kirtee Raparia; Jaehyuk Choi; Derek A Wainwright; Victoria Villaflor; Massimo Cristofanilli; Francis Giles
Journal:  Oncotarget       Date:  2017-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.